Drug Profile
Teriparatide - Rare Disease Therapeutics
Alternative Names: hPTH (1-34) - Rare Disease Therapeutics; Parathyroid hormone (1-34) - Rare Disease Therapeutics; Parathyroid-hormone-1-34; PTH-1-84Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Rare Disease Therapeutics
- Class Diagnostic agents; Osteoporosis therapies; Peptide hormones; Skin disorder therapies
- Mechanism of Action Parathyroid hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hypoparathyroidism
Most Recent Events
- 16 Jun 2005 Discontinued - Phase-III for Hypoparathyroidism in USA (unspecified route)
- 25 Jun 2001 Phase-III clinical trials for Hypoparathyroidism in USA (Unknown route)